Description
.CBC,ESR,FASTING BLOOD SUGAR<HBA1C
.LFT,KFT,LIPID PRIFILE URINE COMPLITE
.T3T4TSH (THYROIDE PROFILE)
₹2,800.00 Original price was: ₹2,800.00.₹1,099.00Current price is: ₹1,099.00.
Profile Name: Comprehensive Diabetes, Thyroid & Organ Health Panel
Test Components & Significance:
CBC & ESR: Evaluates overall blood health, infections, and inflammation.
Fasting Blood Sugar (FBS) & HbA1c: Screening and monitoring of diabetes; HbA1c reflects 2–3 months average glycemia.
Liver Function Test (LFT): Assesses hepatic function, bilirubin metabolism, and drug-induced liver injury.
Kidney Function Test (KFT/RFT): Evaluates renal clearance, electrolyte balance, and detects nephropathy.
Lipid Profile: Measures cholesterol & triglycerides for cardiovascular risk stratification.
Urine Complete (Routine & Microscopy): Detects urinary tract infection, proteinuria, hematuria, and renal abnormalities.
Thyroid Profile (T3, T4, TSH): Assesses thyroid gland function, useful in hypo/hyperthyroidism diagnosis.
Indications:
Annual health check-up
Screening for diabetes, dyslipidemia, thyroid disorders
Monitoring of hepatic and renal function
Early detection of lifestyle-related diseases
Preparation:
8–10 hours fasting required
Water permitted
Avoid heavy exercise or alcohol before testing
Turnaround Time:
Reports available within 24 hours (fast reporting).
.CBC,ESR,FASTING BLOOD SUGAR<HBA1C
.LFT,KFT,LIPID PRIFILE URINE COMPLITE
.T3T4TSH (THYROIDE PROFILE)
Test Name: FBS – Fasting Blood Sugar (Glucose Fasting)
Clinical Significance:
The fasting blood sugar test measures blood glucose after 8–10 hours of fasting. It is widely used for diagnosis and monitoring of diabetes mellitus. Persistent hyperglycemia indicates diabetes, while borderline results suggest impaired fasting glucose (pre-diabetes).
Reference Ranges (may vary by lab):
Normal: 70 – 99 mg/dL
Pre-diabetes (Impaired Fasting Glucose): 100 – 125 mg/dL
Diabetes: ≥126 mg/dL (on two separate tests)
Indications:
Screening for Type 1 and Type 2 Diabetes Mellitus
Monitoring glycemic control in diabetic patients
Evaluation of hypoglycemia
Routine health check-up
Preparation:
Patient should fast for at least 8–10 hours.
Only water is allowed.
Medications should be informed to the doctor/lab.
Test Name: RBS – Random Blood Sugar (Glucose Random)
Clinical Significance:
The Random Blood Sugar test measures glucose concentration in blood at a random time of the day, irrespective of the last meal. It is commonly used for screening and monitoring diabetes mellitus and for evaluation of patients with acute symptoms of hyperglycemia or hypoglycemia.
Reference Ranges (may vary by lab):
Normal: 70 – 140 mg/dL (depending on last meal timing)
Borderline: 141 – 199 mg/dL
Diabetes: ≥200 mg/dL with classic symptoms of diabetes
Indications:
Screening of undiagnosed diabetes
Monitoring of known diabetic patients
Evaluation of emergency cases with hyperglycemia or hypoglycemia
Routine health check-up
Preparation:
No fasting required.
Sample can be taken at any time of the day.
C-Peptide – Fasting, Serum
The C-Peptide Fasting test checks how much insulin your body is making. It is helpful for people with diabetes and those who have low sugar problems.
🔹 Sample Required: Blood (Serum)
🔹 Fasting: Yes, 8–10 hours (only water allowed)
🔹 Report Time: Within 24 hours
Why is this test important?
To check if your body is producing enough insulin
To help doctors know the type of diabetes (Type 1 or Type 2)
To monitor diabetes treatment
To find the cause of frequent low sugar (hypoglycemia)
👉 This test helps your doctor plan the best treatment for you.
Fasting or Random Blood Sugar
Test Name: HbA1c – Glycated Hemoglobin
Clinical Significance:
The HbA1c test measures the percentage of glycated hemoglobin, reflecting the average plasma glucose concentration over the previous 8–12 weeks. It is the gold standard for diagnosis and monitoring of diabetes mellitus. Unlike fasting glucose, HbA1c does not require fasting and is less affected by short-term fluctuations.
Reference Ranges (may vary by lab):
Normal: <5.7%
Pre-diabetes: 5.7% – 6.4%
Diabetes: ≥6.5%
Target for good control in diabetics: <7.0% (as per ADA guidelines)
Indications:
Diagnosis of Type 2 Diabetes Mellitus and Pre-diabetes
Long-term monitoring of glycemic control in diabetic patients
Assessing risk for microvascular and macrovascular complications
Preparation:
No fasting required
Sample can be collected at any time of the day
Turnaround Time:
Fast reporting – Results available within 24 hours (same day reporting).

Reviews
There are no reviews yet.